Daratumumab in Treating Transplant-Eligible Participants With Multiple Myeloma (Q62812962)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Daratumumab in Treating Transplant-Eligible Participants With Multiple Myeloma |
clinical trial |
Statements
Phase II Trial of Daratumumab for Transplant-Eligible Multiple Myeloma Patients (English)
0 references
9 April 2018
0 references
1 April 2019
0 references
50
0 references
18 year
0 references
64 year
0 references